Back to funds

Logos Global Management LP

Updated 3 days ago

Managed by Logos Global Management Lp • Latest filing Q3 2026

Portfolio value
$1.9B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
89.1%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$1.7B
Q1 2026$2B
Q2 2026$2.3B
Q3 2026$1.9B

Top holdings

75 positions as of Q3 2026

View filing
P

PRAXIS PRECISION MEDICINES I

Value
$123.8M
Shares
425.0K
% Port
6.45%
R

REVOLUTION MEDICINES INC

Value
$123.2M
Shares
600.0K
% Port
6.42%
I

IDEAYA BIOSCIENCES INC

Value
$109.5M
Shares
2.85M
% Port
5.71%
E

ERASCA INC

Value
$86.5M
Shares
5.90M
% Port
4.51%
A

ABIVAX SA

Value
$86.1M
Shares
870.0K
% Port
4.49%
C

CG ONCOLOGY INC

Value
$69.1M
Shares
975.0K
% Port
3.60%
I

DISC MEDICINE INC

Value
$66.4M
Shares
1.01M
% Port
3.46%
B

BIONTECH SE

Value
$63.9M
Shares
650.0K
% Port
3.33%
T

TANGO THERAPEUTICS INC

Value
$53.6M
Shares
2.15M
% Port
2.80%
M

MADRIGAL PHARMACEUTICALS INC

Value
$50.4M
Shares
100.0K
% Port
2.63%
E

ENLIVEN THERAPEUTICS INC

Value
$49.5M
Shares
1.08M
% Port
2.58%
D

DYNE THERAPEUTICS INC

Value
$48.3M
Shares
3.00M
% Port
2.52%
A

ACHIEVE LIFE SCIENCE INC

Value
$48.1M
Shares
5.95M
% Port
2.51%
O

OCULAR THERAPEUTIX INC

Value
$46M
Shares
6.00M
% Port
2.40%
D

DIANTHUS THERAPEUTICS INC

Value
$44M
Shares
500.0K
% Port
2.29%
A

ARRIVENT BIOPHARMA INC

Value
$40.9M
Shares
1.35M
% Port
2.13%
C

COGENT BIOSCIENCES INC

Value
$40M
Shares
1.25M
% Port
2.09%
E

ERASCA INC

Value
$36.6M
Shares
2.50M
% Port
1.91%
N

NEUROCRINE BIOSCIENCES INC

Value
$35.5M
Shares
250.0K
% Port
1.85%
B

BELITE BIO INC

Value
$34M
Shares
200.0K
% Port
1.77%

Explore